Kinea Bio Secures $1.1M Jain Foundation Investment and Solid Biosciences Capsid License to Advance Novel Gene Therapy for Dysferlinopathy, a Rare Neuromuscular Disease

businesswire

Kinea Bio Secures $1.1M Jain Foundation Investment and Solid Biosciences Capsid License to Advance Novel Gene Therapy for Dysferlinopathy, a Rare Neuromuscular Disease – NEWSnet – News… as it used to be

More Press Releases

June 24, 2026

One Stop Auto Body & Paint – Collision Repair Specialists Becomes Certified PeelClear Installer in Phoenix

June 24, 2026

Artisan Fence Decks & Patio Covers Reports Increased Fence Installation Requests Across Vancouver, WA

June 24, 2026

Aspen Psychology Group Welcomes New Clinician Lindsey Ryland, MSW, RSW

June 24, 2026

Kinea Bio Secures $1.1M Jain Foundation Investment and Solid Biosciences Capsid License to Advance Novel Gene Therapy for Dysferlinopathy, a Rare Neuromuscular Disease

One Stop Auto Body & Paint – Collision Repair Specialists Becomes Certified PeelClear Installer in Phoenix

Artisan Fence Decks & Patio Covers Reports Increased Fence Installation Requests Across Vancouver, WA

Aspen Psychology Group Welcomes New Clinician Lindsey Ryland, MSW, RSW

LUMINTOP Pixel 300 Turns Everyday Carry into an Interactive Lighting Experience